Feb 28, 2017
Alkaloid marked 6% growth in consolidated sales, investments of mkd 712.28 million and 157 new employments in the period January - December 2016
Alkaloid marked 6% growth in consolidated sales, investments of mkd 712.28 million and 157 new employments in the period January - December 2016
Alkaloid AD Skopje achieved positive financial results in the period January-December 2016 - shows the unaudited standalone and unaudited consolidated Income Statement.
According to the unaudited standalone Income Statement, in the period January- December the sales reached the amount of MKD 6,418,580,770 - 7% up on the same period last year. Earnings before interest, taxes, depreciation and amortization (EBITDA), which amount to MKD 1,208,748,918 marked an increase of roughly 13%, whereas the net profit rose by 9%.
In the period January – December the total consolidated sales reached MKD 8,292,770,038 – an increase of 6% compared to the same period last year. Consolidated sales in the domestic market increased by 3%, while the total consolidated export of the company increased by 8%. Out of the total consolidated sales, 40% were realized in the domestic market, while the foreign markets account for 60%. The breakdown by region shows that the countries of South-East Europe account for 35% of the sales, Russia and CIS – 6%, 17% of the sales were realized in the countries from Western Europe (EU and EFTA), while the other markets account for 2% of the total consolidated sales. The highest rise in export markets was seen in the following countries: USA – 30%, Russia – 15%, Romania – 63%, Slovenia - 13%, Poland – 141%, Great Britain – 125%, Hungary- 135%, Turkey – 72%, Czech Republic - 122%, Albania – 47% etc.
The breakdown of total consolidated sales by group of products shows that the best sellers are the products from the segment Pharmaceuticals – 83%, with OTC products accounting for 19%, cardiovascular products - 17%, neurological products – 13%, antibiotics - 13% etc. The Chemistry Cosmetics Botanicals segment accounts for 17% of the total consolidated sales, or more precisely Chemistry – 3%, Cosmetics – 10% and Botanicals – 4%.
Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA), which reached MKD 1,296,423,420 saw an increase of 12%, whereas the net consolidated profit amounting to MKD 731,818,674 went up by 10%.
The total investments in non-current assets for the period January – December 2016 amounted to MKD 712,282,757.
In the period January – December 2016 Alkaloid recruited 157 new employees in the Republic of Macedonia.